BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Penn Engineering Events - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Penn Engineering Events
X-ORIGINAL-URL:https://seasevents.nmsdev7.com
X-WR-CALDESC:Events for Penn Engineering Events
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190709T103000
DTEND;TZID=America/New_York:20190709T113000
DTSTAMP:20260408T171920
CREATED:20190708T195150Z
LAST-MODIFIED:20190708T195150Z
UID:1705-1562668200-1562671800@seasevents.nmsdev7.com
SUMMARY:BE Seminar: Next Generation Orthobiologics:  Advanced Growth Factor and Biomaterials Engineering
DESCRIPTION:The standard of care for augmenting surgical bone repair or regeneration remains bone graft harvested from the patient despite a lack of sufficient quantity or quality of graft in many clinical cases.  Bone morphogenetic protein (BMP) therapeutics have been successfully developed and commercially marketed as substitutes for bone graft.  Although the clinical success of BMP\, especially in spinal fusion\, is well-documented\, safety issues related to the required therapeutic dose\, sub-optimal delivery and off-label use have generated substantial controversy.  To address these issues and develop a next generation BMP product with improved efficacy and safety\, we designed a series of novel recombinant human chimeric proteins with enhanced binding affinities to key cellular receptors involved in bone formation.  In parallel\, a novel biomaterial scaffold was developed to improve the local retention time of these “designer” BMPs and reduce the risk of adverse events.  Through this combination of protein engineering and specialized biomaterial development\, large animal studies have demonstrated efficacy at substantially lower doses than those required with existing BMP products and the potential to provide a safer and more effective option for surgeons and patients.
URL:https://seasevents.nmsdev7.com/event/be-seminar-next-generation-orthobiologics-advanced-growth-factor-and-biomaterials-engineering/
LOCATION:Class of 62 Auditorium\, John Morgan Building\, 3620 Hamilton Walk\, Philadelphia\, PA\, 19104
CATEGORIES:Seminar
ORGANIZER;CN="Bioengineering":MAILTO:be@seas.upenn.edu
END:VEVENT
END:VCALENDAR